Josie M Linaweaver

Josie M. Linaweaver serves as a Contract Specialist within the National CMOP Office of the Department of Veterans Affairs, where she plays a pivotal role in securing the domestic production and distribution of mission-critical pharmaceuticals and medical supplies for veterans. Her responsibilities encompass the full lifecycle of acquisition activities—from market research and solicitation development to contract award and administration—ensuring compliance with federal procurement regulations while advancing the agency’s strategic goal of supply chain resilience. She primarily manages acquisitions for pharmaceutical manufacturing, in-vitro diagnostic substances, and related medical consumables, ensuring timely, secure, and sovereign production capabilities are maintained. Linaweaver maintains consistent working relationships with a core group of specialized contractors, including ALL IN SOLUTIONS LLC, ANSIBLE GOVERNMENT SOLUTIONS LLC, and INNOVATION ASSOCIATES, INC., each of which provides technical expertise in pharmaceutical formulation, sterile compounding, and medical logistics. Her contracting patterns reflect a preference for established vendors with proven capabilities in cGMP environments and FDA-regulated manufacturing, fostering long-term partnerships grounded in quality assurance and regulatory compliance. While she engages a broad vendor base, the majority of awards are concentrated among a small cohort of high-capacity, mission-aligned contractors. Her procurement strategy prioritizes small business participation, with approximately 35.5% of awards structured as Total Small Business Set-Asides under FAR 19.5 and an additional 4.4% designated for Service-Disabled Veteran-Owned Small Businesses. This reflects a deliberate commitment to socioeconomic goals, aligning with VA’s mandate to support veteran-owned enterprises while maintaining operational readiness. Though the majority of contracts are unrestricted, she actively leverages set-aside authorities to broaden vendor diversity without compromising mission requirements. Linaweaver’s technical focus centers on NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), which together account for over 75% of her portfolio. She specializes in procuring sterile injectables, radiopharmaceuticals, diagnostic reagents, and associated chemical intermediates, demonstrating deep familiarity with cGMP, FDA labeling requirements, and cold chain logistics. Her expertise ensures the agency’s domestic manufacturing base remains capable of meeting the complex, high-integrity demands of veteran healthcare.